# Buspirone in Parkinson's Disease

> **NCT02803749** · PHASE2 · COMPLETED · sponsor: **University of Rochester** · enrollment: 21 (actual)

## Conditions studied

- Parkinson Disease
- Anxiety

## Interventions

- **DRUG:** Buspirone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02803749
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-01
- **Final completion:** 2019-01-25
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02803749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02803749, "Buspirone in Parkinson's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02803749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*